SEATTLE, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ... today reported financial results for the fourth quarter and full year ended December 31, 2024.
ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today reported financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback